Development-preview notice
Privacy policy
This notice describes the development preview and its limited, non-medical public-interest email paths. A final privacy policy and applicable patient notices require review before real-patient services begin.


Synthetic practice and limited public interest messages
Use synthetic information in application accounts and operational workflows. The public early-interest, private-consultation and cancellation-review forms accept limited non-medical contact information only and may send a transactional receipt after the request is accepted. Do not include a patient name, diagnosis, order, specimen record, insurance, payment information or other health information.

Information used by the preview
Account services process account and authentication information. The application stores submitted practice workflow records and audit events. Hosting and account providers may process technical information needed to operate and secure the service.
An unfinished collection request stays in memory on the open page; closing or reloading clears it. Authentication uses browser storage to maintain the signed-in session. Signing out clears the active session on that browser.

Access and communications
Account and workflow access is limited by role and authorization. General email is for business questions and limited public-interest requests, not health records. A public form receipt only acknowledges that a request was received; live client email and text notifications are not enabled. The preview does not enable marketing analytics or advertising trackers.

Questions, correction or deletion requests
Use compliance@phlebosphere.com or the contact page to ask for help without including sensitive records. Identity and authority must be checked before any account or record change. Retention periods and the final correction/deletion procedure require review before launch; this notice does not promise immediate deletion of audit evidence.

Before live services
Vendor agreements, data flows, retention rules, patient rights and operational safeguards must be reviewed. This development notice is not a claim of HIPAA compliance. Notice date: September 11, 2026.

